NPPA cuts MRPs of 543 cancer drug brands by up to 93%

India's National Pharmaceutical Pricing Authority (NPPA) has cut the maximum retail prices of 543 cancer drug brands and packs by up to 93%, though prices of some major innovator medicines remain unchanged.

Detected & updated continuously · Source: Nebula